Charme inks first Fund III deal

Italian buyout house Charme Capital Partners has acquired a genetic testing company from its third fund, which has exceeded its €500m target.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this